A personal update says the poster dropped 2.2 pounds this week and about 98 pounds since a Disney trip in January 2025. One person's account, not a study.
Recap by typeshit. Post by Facebook on Facebook.
Chokshi notes the sales were 0.4% of Lilly's $23 billion quarter, and that Divi's Labs hasn't announced any role in making the drug.
The surgeon says that after a 45 lb loss on a GLP-1, getting enough daily protein with a low appetite becomes the harder part.
She says the cause is a calorie surplus: some patients still manage high calorie foods and aren't exercising enough while on the drugs.
A short piece on how cravings and snacking urges may change for people taking GLP-1 drugs. Details are thin, so tap through for the full story.
AJMC has a video on heart failure care making the case that these two drug classes each have a separate role and can't simply be swapped for one another.
Challenge 3 asks entrants to design a protein that activates the receptor semaglutide and tirzepatide target in diabetes and obesity treatment.
Loading…